相关实验视频

Updated: Sep 14, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

低基质性头癌:导航患者的发展轨迹和更广泛的影响

Juliette Thariat¹, Jihane Lehyanti², Pierre Boisselier³

¹Department of Radiotherapy, centre François-Baclesse, Caen, France; Corpuscular Physics Laboratory, IN2P3, EnsiCaen, CNRS UMR 6534, université de Normandie, Caen, France; Groupe d'oncologie radiothérapie tête et cou (Gortec), 4 bis, rue Émile-Zola, 37000 Tours, France.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

|July 24, 2025

概括

单独使用立体性废除性放射疗法是对小卵性转移性头癌的毒性较低的选择. 这种降级策略显示了比系统治疗更好的生存率和更好的生活质量.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
头部和部癌症研究研究

背景情况:

脑和部状细胞癌 (Oligometastatic head and neck squamous cell carcinoma,HNSCC) 是一种独特的临床状态,通常被排除在标准的转移性试验之外.
目前转移性HNSCC的治疗模式主要集中在全身疗法上,对寡头转移性疾病的缓解策略的研究有限.

研究的目的:

评估单独使用立体性除性放射治疗 (SABR) 与与SABR结合的全身疗法的疗效和毒性,用于患有真正的元慢性寡度转移性HNSCC的患者.
评估降级战略对生存,无进展生存和生活质量的影响.

主要方法:

这项研究审查了历史文献和来自Gortec 2014-04 Omet第二阶段随机试验的数据.
患有多达三次寡聚转移的患者,未经先前的全身疗法诱导,随机分配给接受单独SABR或化疗加SABR.
分析了包括生存,无进展生存,毒性 (3-4级) 和生活质量在内的结果.

主要成果:

在两个治疗臂中,一年生存率超过了85%.
虽然化学疗法加SABR的无进展生存时间较长 (10个月与7.5个月),但单独使用SABR对转移性复发没有显著的负面影响.
单靠SABR,与综合方法相比,显著降低了3-4级毒性 (8.8%vs. 60%) 和更好的生活质量.

结论:

单独采用立体性除性放射疗法是一种可行的,毒性较低的替代方案,用于治疗真正的脑和部状细胞癌.
在这种情况下,精确的患者选择对于优化SABR的结果至关重要.
需要进一步的研究来澄清免疫疗法在寡头转移性HNSCC中的作用,并挑战单独SABR的疗效.

关键词:

癌症癌症癌症癌症头部和部的新生瘤.一个ORLRLRL.有氧基质扩散症 (Oligometastasis)基甲酶是基甲酶的一种.无线电疗法的立体有毒性.立体性身体放射疗法立体性身体放射治疗头部和部的

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...